Related Experiment Video
Updated: Feb 16, 2026

Oral Biofilm Analysis of Palatal Expanders by Fluorescence In-Situ Hybridization and Confocal Laser Scanning Microscopy
Published on: October 20, 2011
Biofilms and beyond: expanding echinocandin utility
Emily L Larkin1, Sharvari Dharmaiah1, Mahmoud A Ghannoum1
1Center for Medical Mycology, 11100 Euclid Ave, Case Western Reserve University and University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
Echinocandins are increasingly vital antifungal drugs, recommended as first-line therapy for candidaemia. Research explores their use against resistant fungi, biofilms, and inflammatory bowel disease.
Area of Science:
- Mycology
- Infectious Diseases
- Pharmacology
Background:
- Echinocandins have been clinically used for over 15 years.
- Increasing fluconazole resistance and shifts to non-albicans Candida species highlight the growing importance of echinocandins.
- Recent guidelines (2016) recommend echinocandins as first-line treatment for candidaemia.
Purpose of the Study:
- To review the evidence and potential utility of echinocandins and 1,3-β-d-glucan synthesis inhibition.
- To explore emerging applications of echinocandins.
Main Methods:
- Literature review of existing evidence.
- Analysis of current trends in antifungal resistance and treatment guidelines.
- Exploration of preliminary research on new applications.
Main Results:
- Echinocandins demonstrate efficacy, tolerability, and safety.
- Potential new uses include treatment of biofilm infections, multidrug-resistant Candida auris, and dermatophytes.
- Emerging data suggests potential in treating inflammatory bowel disease (IBD) linked to the mycobiome.
Conclusions:
- Echinocandins are a cornerstone in treating invasive candidiasis.
- Their mechanism of action (1,3-β-d-glucan synthesis inhibition) offers promise for novel therapeutic strategies.
- Further research is warranted to validate echinocandin utility in biofilm infections, MDR pathogens, and IBD.
Related Concept Videos
Biofilms
Bacterial Signaling
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Quantifying Work
Seed Structure and Early Development of the Sporophyte
Exceptions to the Octet Rule

